Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development

Go back to Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
(NASDAQ: ENVB) Delayed: 1.48 --0 (-0%)
Previous Close $1.48    52 Week High
Open $1.48    52 Week Low
Day High $1.48    P/E N/A 
Day Low $1.48    EPS
Volume 650